CIMS India vs IWill
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CIMS India
This medical reference app provides healthcare professionals with a comprehensive drug database, disease management guidelines, and the latest medical news. It offers quick access to clinical information and expert insights to support informed decision-making at the point of care.
- Drug dosing and interaction information
- Disease management guidelines
- Latest medical news and updates
- Expert video interviews
- Concise and comprehensive drug database
Read full descriptionHide full description
For over 50 years, MIMS has provided trusted clinical information for over 2 million healthcare professionals in Asia. Designed for busy individuals on the go, the MIMS app is a one-stop medical resource to support clinical decisions at the point of care. The most trusted drug and medical reference tool for doctors in Asia. The MIMS Mobile app for IOS™ is available for free. For more information, visit www.mims.com/mobile-app __________________________________________________________________ Key features available in our app: • Drug Information Search for drug dosing information or specific drug interactions, and find the answers you need in seconds with our concise and comprehensive drug database. • Disease & Condition Management Guidelines Review a complete disease management guide and be assured of reliable content fully substantiated by validated references and internationally recognised research, to enable you to make better-informed prescribing decisions. • Medical News & CME Updates Read the latest news available across various specialties in Asia through our renowned publications (Medical Tribune, JPOG, Oncology Tribune, etc), and keep your knowledge and skills current with changes in medicine. • Multimedia Watch insightful video interviews focusing on treatment options, disease management and latest updates by experts from various specialties, and upgrade your medical knowledge.
IWill
This app offers a personalized therapeutic journey for emotional and mental well-being. It begins with an assessment to create a tailored therapy module and pairs you with a qualified therapist. It also provides a daily feed of inspirational content for positivity and self-help.
- Personalized therapeutic journeys
- Initial assessment for tailored modules
- Therapist matching
- Daily feed of beneficial content
- Inspirational quotes
- Real-life stories of struggles and triumphs
Read full descriptionHide full description
I will app is your "support system" designed for needs of greater emotional and mental well-being It’s the best choice for you, if you want to go on a customized journey of recovery or self-improvement. This is why: * The therapeutic journey at I WILL has been designed like a personal journey with your unique needs at the center. *The journey begins with an assessment of your concerns; this forms the basis of designing a therapy module best suited for you. * You are then paired with a therapist who is best qualified to address your specific issues and goals. This therapist then walks with you on your recovery path. Remember, even if you are not seeking active therapy, the I WILL app is a therapeutic space where you can find positivity and understanding. The app creates this space for you via a daily feed of beneficial content, including real-life stories of struggles and triumphs, inspirational quotes and self-help. It’s all free and available for you.
Screenshots
Verdict
The clearest difference is review sentiment: IWill at 100% against CIMS India's 25%. IWill also leads on rating (5.0 vs 2.0) and ads (none vs shown). On price, update cadence, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
IWill holds the better App Store score, 5.0 against 2.0. Both are backed by a comparable volume of ratings — 2 and 7 respectively. Written reviews point the same way: 25% of CIMS India's written reviews are positive against 100% of IWill's.
Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on September 7, 2026 and June 29, 2026 respectively.
| Parameter | CIMS India | IWill |
|---|---|---|
| Price | Free | Free |
| Rating | 2.0 (2 ratings) | 5.0 (7 ratings) — better |
| Positive reviews | 25.0% of reviews | 100.0% of reviews — better |
| Number of ratings | 2 | 7 — better |
| Update frequency | Every 2 months | Every 2 months |
| Ads | Yes | No — better |
| In-app purchases | No | No |
| Monetization | Ad-supported | Free — better |
| Devices | iPhone, iPad, iPod — better | iPhone, iPod |
| Requires iOS | 12.4 — better | 13.0 |
| Further details — not scored | ||
| Size | 44 MB | 138 MB |
| Age rating | 17+ | 4+ |
| Developer | MIMS PTE. LTD. | ePsyClinic Healthcare Private Limited |
Customer experience
CIMS India
IWill
In-app purchases
CIMS India
No in-app purchases
IWill
No in-app purchases







